Tradestie Institutional Equity Comparison Engine
NMAD vs PALI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PALI Overall Edge
PALI Captures Institutional Edge (2โ1 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palisade Bio, Inc. Common Stock (PALI) driven by superior Valuation, Growth & Margin while NMAD counters with relative strength in Momentum & Technical. Fundamentally, NMAD trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus PALI at N/M Forward P/E and -9625.4% operating margin (+0.0% YoY). In options structure, NMAD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PALI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
PALI
NMAD N/M vs PALI N/M Fwd P/E
Growth & Margin Winner
PALI
Op Margin N/A vs -9625.4% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
NMAD
1Y -65.1% vs -61.3% ยท 52W Pos 8% vs 0%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
NMAD
US Equity
NMAD
Institutional Equity
$2.56
+13.53% 1D
Market Cap
N/A
1M Return
-28.89%
1Y Return
-65.12%
Forward P/E
N/M
Unified AI Score
47.9 / 100
HOLD
Tech 43.0
Fund 49.0
Flow 50.0
Mom 70.0
PALI
NASDAQ
Palisade Bio, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.84
-9.24% 1D
Market Cap
$166.1M
1M Return
-37.79%
1Y Return
-61.29%
Forward P/E
N/M
Unified AI Score
39.3 / 100
SELL
Tech 25.0
Fund 43.0
Flow 50.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NMAD -65.12%
PALI -61.29%
Spread: +6.29 pp (PALI Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NMAD TTM Op. Margin: N/A
PALI TTM Op. Margin: -9625.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMAD vs PALI. Trailing 12-month operating profitability (NMAD N/A vs PALI -9625.4%) and valuation multiples (NMAD N/M vs PALI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NMAD | PALI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $166.1M | Larger Scale | PALI |
| Trailing P/E Ratio Valuation | N/M | 1.0x | Lower Multiple | PALI |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | PALI |
| Operating Margin (TTM) Profitability | N/A | -9625.4% | Higher Margin | PALI |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | PALI |
| Return on Equity (ROE) Capital Efficiency | N/A | -75.6% | Higher ROE | PALI |
| 52-Week Range Position Momentum | 8% ($2โ$8) | 0% ($1โ$3) | Stronger Trend | NMAD |
| Beta / 30D Volatility Risk Regime | 0.52ฮฒ ยท 173% Vol | 1.44ฮฒ ยท 70% Vol | Lower Realized Risk | PALI |
| Unified Institutional Score Composite Signal | 47.9 / 100 (HOLD) | 39.3 / 100 (SELL) | Higher Composite | NMAD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NMAD vs PALI Buy Guide
NMAD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
PALI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NMAD nor PALI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.